Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Systematic Review

Autor: Mohammad Hadi Sadeghian, Masumeh Ghazanfarpour, Hossein Ayatollahi, Ehsan Yazdandoust, Maryam Sheikhi, Seyyede Fatemeh Shams, Arezoo Shajiei, Sepideh Shakeri
Rok vydání: 2017
Předmět:
0301 basic medicine
Oncology
medicine.medical_specialty
Poor prognosis
Databases
Factual

inv(16)
medicine.disease_cause
Bioinformatics
lcsh:RC254-282
Translocation
Genetic

03 medical and health sciences
0302 clinical medicine
CBF-AML
Internal medicine
White blood cell
hemic and lymphatic diseases
medicine
Humans
Core binding factor acute myeloid leukemia
t(8
21)
Mutation
business.industry
lcsh:RC633-647.5
Myeloid leukemia
General Medicine
lcsh:Diseases of the blood and blood-forming organs
Hematology
medicine.disease
Prognosis
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Survival Rate
Leukemia
Leukemia
Myeloid
Acute

Proto-Oncogene Proteins c-kit
030104 developmental biology
medicine.anatomical_structure
c-kit
030220 oncology & carcinogenesis
Chromosome Inversion
Bone marrow
business
Leukemic Blasts
Zdroj: Hematology/Oncology and Stem Cell Therapy, Vol 10, Iss 1, Pp 1-7 (2017)
ISSN: 1658-3876
DOI: 10.1016/j.hemonc.2016.08.005
Popis: Objective/background: Acute myeloid leukemia (AML) is defined as leukemic blast reproduction in bone marrow. Chromosomal abnormalities form different subgroups with joint clinical specifications and results. t(8;21)(q22;q22) and inv(16)(p13;q22) form core binding factor-AML (CBF-AML). c-kit mutation activation occurs in 12.8–46.1% of adults with CBF leukemia. These mutations occur in 20–25% of t(8;21) and 30% of inv(16) cases. Methods: In this systematic review, we searched different databases, including PubMed, Scopus, and Embase. Selected articles were measured based on the inclusion criteria of this study and initially compared in terms of titles or abstracts. Finally, articles relevant to the subject of this review were retrieved in full text. Twenty-two articles matched the inclusion criteria and were selected for this review. Results: In this study, c-kit mutations were associated with poor prognosis in AML patients with t(8;21) and inv(16). In addition, these mutations had better prognostic effects on AML patients with inv(16) compared with those with t(8;21). Conclusion: According to the results of this study, c-kit mutations have intense, harmful effects on the relapse and white blood cell increase in CBF-AML adults. However, these mutations have no significant prognostic effects on patients. Keywords: CBF-AML, c-kit, t(8;21), inv(16)
Databáze: OpenAIRE